Due to the increasing cases of conditions such as cancer, key players and the government are heavily investing in initiatives such as cell-free DNA isolation and extraction for diagnosing cancer. Hence, there has been an increased demand for cell-free DNA isolation kits, tubes, and other consumables.
The constant investments, growing adoption of cell-free DNA isolation and extraction kits are propelling the growth of the global cell-free DNA isolation and extraction market.
The global cell-free DNA isolation and extraction market was valued at $169.9 million in 2020 and is expected to reach $735.1 million by 2031, witnessing a CAGR of 14.19% during the forecast period 2021-2031.
Non-encapsulated DNA in the bloodstream is known as cell-free DNA. It is released into the circulatory system throughout the body. It can be found in plasma, cerebral spinal fluid, pleural fluid, urine, saliva, and other fluids in the body. Most of the plasma cell-free DNA molecules originate from the hematopoietic system in the body of healthy individuals.
However, in certain pathological or psychological conditions such as organ transplants, pregnancy, immune diseases, and cancers, additional DNA can be released into the bloodstream by the affected tissues. Furthermore, cell-free DNA can be very instrumental in helping healthcare professionals detect abnormalities in individuals by a non-invasive method.
For example, non-invasive prenatal test (NIPT) can help screen several common chromosomal conditions in the fetus by analyzing cell-free DNA.
The analysis of nucleic acids and protein biomarkers is a popular method for cancer diagnosis, risk stratification, and molecular targeting therapeutics. However, biomarker studies are based on the analysis of tumor tissues that are acquired from invasive surgical procedures such as biopsy.
Newer techniques with non-invasive diagnoses are needed. Cell-free DNA analysis has attracted increasing attention due to its non-invasive nature and easy accessibility.
Cancer patients sometimes have a high level of cell-free DNA in their serum or plasma due to cellular breakdown (cellular necrosis or apoptosis). This cell-free DNA can be used for cancer diagnosis, treatment response prediction, disease progression monitoring, and as a cancer prognostic biomarker.
The global cell-free DNA isolation and extraction market size is increasing with the growing number of players competing to develop novel products for the isolation and extraction of cell-free DNA from different sample types. Several established companies are trying to stay at the top by launching new products while raising funds to develop innovative and new products in this market space.
Key market players of the global cell-free DNA isolation and extraction market witnessed product launch, product approval and business funding, and synergistic activities majorly during the period January 2018-November 2021.
1. Rising prevalence of cancer
2. Strategic initiatives by key players in the industry
3. Growth in the field of microbial sequencing
1. Genomic data protection
2. Rigid regulatory standards
3. High cost of automated instruments
Rapid technological developments are taking place in the cell-free DNA isolation market, which will soon overpower the market challenges and aid in better diagnosis.
BIS Research’s healthcare team provides valuable and actionable information to its clients on trends and technologies disrupting the different segments of the healthcare industry
One of the key highlights of our market intelligence solution is the Deep Tech M-A-P™ approach. M-A-P™ includes Market, Application, and Product.
Clients at BIS Research can choose from various services, including syndicated research reports, custom research, expert consultations, individually or in any combination of the three based on their requirements.
In our recent global cell-free DNA isolation and extraction market report, you get details and answers to the following details:
1. Estimated global cell-free DNA isolation and extraction market size
2. CAGR of the market for the forecast period 2021-2031
3. Key trends, market drivers, and opportunities in the global cell-free DNA isolation and extraction market
4. Challenges in the global cell-free DNA isolation and extraction market
5. Revenue forecast and market coverage of the industry
6. Revenue of each segment of the global cell-free DNA isolation and extraction market
7. Top stakeholders and their roles in the global cell-free DNA isolation and extraction market
8. Underlying structures resulting in the emerging trends within global cell-free DNA isolation and extraction ecosystem
9. Impact of COVID-19 on global cell-free DNA isolation and extraction market
10. Key development strategies of major players to sustain competition
11. Regulatory implications in developed and developing regions pertaining to the use of cell-free DNA isolation and extraction targeted therapies
12. Potential entry barriers for companies willing to enter a particular region
13. Companies expected to be highly disruptive in the future and their respective reasons
Read more about the global cell-free DNA isolation and extraction market in our report. Request a sample here. https://bisresearch.com/requestsample?id=1251&type=download